2025
SJR Q2
JCR Q3 · 2,9
62 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Bone and Mineral Metabolism
- Yayıncı
- Springer
- Ülke
- Japan · Asiatic Region
- Tür
- journal
- ISSN
-
0914877914355604
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,799
- Quartile Q2
- H-Index 91
- Atıf/yayın 2,49
- Doküman (3y) 272
- Atıf (3y) 710
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,9
- 5Y JIF 3,2
- JCI 0,55
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Endocrinology Q2
- Endocrinology, Diabetes and Metabolism Q2
- Medicine (miscellaneous) Q2
- Orthopedics and Sports Medicine Q2
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Endocrinology & Metabolism | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,799 | 2,9 | 3,2 | 0,55 | Q3 | 91 |
| 2024 | Q2 | Q3 | 0,86 | 2,2 | 2,8 | 0,55 | Q3 | 88 |
| 2023 | Q2 | Q3 | 0,766 | 2,4 | 2,7 | 0,62 | Q3 | 88 |
| 2022 | Q2 | Q3 | 0,748 | 3,3 | 2,9 | 0,65 | Q2 | 88 |
| 2021 | Q2 | Q3 | 0,585 | 3 | 2,9 | 0,64 | Q3 | 88 |
| 2020 | Q2 | Q3 | 0,721 | 2,6 | 2,6 | 0,73 | Q2 | 88 |
| 2019 | Q2 | Q3 | 0,666 | 2,3 | 2,3 | 0,75 | Q2 | 88 |
| 2018 | — | Q3 | — | 2,3 | 2,3 | 0,79 | Q2 | — |
| 2017 | Q2 | Q3 | 0,763 | 2,5 | 2,3 | 0,75 | Q2 | 88 |
| 2016 | Q2 | Q3 | 0,864 | 2,4 | 2,4 | — | — | 88 |
| 2015 | Q1 | Q3 | 0,846 | 2,3 | 2,2 | — | — | 88 |
| 2014 | Q1 | Q3 | 0,943 | 2,5 | 2,3 | — | — | 88 |
| 2013 | Q1 | Q3 | 0,85 | 2,1 | 2,3 | — | — | 88 |
| 2012 | Q1 | Q3 | 0,879 | 2,2 | 2,4 | — | — | 88 |
| 2011 | Q1 | Q2 | 0,9 | 2,3 | 2,3 | — | — | 88 |
| 2010 | Q1 | Q2 | 0,987 | 2,2 | 2,2 | — | — | 88 |
| 2009 | — | Q3 | — | 1,9 | 1,9 | — | — | — |
| 2008 | — | Q3 | — | 2,1 | 2,2 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,6 | — | — | — |
| 2006 | — | Q3 | — | 1,5 | — | — | — | — |
| 2005 | — | Q3 | — | 1,5 | — | — | — | — |
| 2004 | — | Q3 | — | 1,5 | — | — | — | — |
| 2003 | — | Q3 | — | 1,6 | — | — | — | — |
| 2002 | — | Q3 | — | 1,3 | — | — | — | — |
| 2001 | — | Q3 | — | 1,2 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 114/198 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 100/191 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 133/193 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 109/195 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 121/186 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 106/189 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 86/145 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 81/136 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 108/146 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 98/139 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q2 | 114/146 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 98/140 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 106/143 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 91/139 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 103/145 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 79/136 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 94/142 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 72/133 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 88/138 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 67/128 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 89/133 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 65/124 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 75/128 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 62/123 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 77/124 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 64/124 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 74/122 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 62/121 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 68/122 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 56/112 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 72/116 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 47/106 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 76/105 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 54/93 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 67/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 44/83 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 81/92 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 54/81 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 75/93 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 48/76 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 67/89 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 47/72 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 64/87 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 41/71 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 63/88 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 39/72 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 57/88 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 45/74 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 62/90 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 42/75 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 70/89 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 48/74 |